Previous 10 | Next 10 |
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus PR Newswire Initiation of the Phase 2a portion follows DRC review of positive safety and tolerabilit...
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference PR Newswire MARINA DEL REY, Calif. , Sept. 21, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacter...
2023-08-22 12:47:19 ET Gainers: VinFast Auto ( VFS ) +123% . AMTD Digital ( HKD ) +67% . Fulcrum Therapeutics ( FULC ) +51% . Hitek Global ( HKIT ) +30% . Fabrinet ( FN ) +28% . BioNexus Gene Lab Corp. ( BGLC ) +22% ....
2023-08-14 09:41:38 ET Armata Pharmaceuticals press release ( NYSE: ARMP ): Q2 GAAP EPS of -$0.17. Revenue of $0.98M (-47.9% Y/Y). For further details see: Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , Aug. 14, 2023 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on p...
2023-08-02 10:17:25 ET Gainers: TRxADE HEALTH ( MEDS ) +60% . Armata Pharmaceuticals ( ARMP ) +17% . Teva Pharmaceutical Industries ( TEVA ) +13% . CareDx ( CDNA ) +9% . Mallinckrodt ( MNK ) +9% . Losers: Adamis Pharmaceut...
2023-07-27 08:38:02 ET Mersana Therapeutics ( MRSN ) -74% announces topline data from UPLIFT clinical trial in patients with platinum-resistant Ovarian Cancer and strategic reprioritization. Biohaven ( BHVN ) -27% . Yellow Corporation ( YELL ) -26% . ...
2023-07-26 12:59:58 ET Gainers: Vicor Corporation ( VICR ) +51% . Tupperware Brands Corporation ( TUP ) +43% . ABVC BioPharma ( ABVC ) +39% . Armata Pharmaceuticals ( ARMP ) +30% . PacWest Bancorp ( PACW ) +27% . XPeng ( XP...
2023-07-24 10:09:58 ET Gainers: Armata Pharmaceuticals ( ARMP ) +19% . Janux Therapeutics ( JANX ) +11% . Amylyx Pharmaceuticals ( AMLX ) +8% . Coherus BioSciences ( CHRS ) +7% . Nuwellis ( NUWE ) +7% . Losers: Kodiak...
2023-07-11 08:50:31 ET Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals ( NYSE: ARMP ) enters into a credit and security ...
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...